Novacutan FBio DVS Light Fillers (1 x 1ml)

€ 72,60 Incl. VAT

Manufacturer: Laboratoires Fijie France
Brand: Novacutan
Composition: HA 20 mg/ml
Packing: 1ml x 1 syringe
Application: Wrinkles on the forehead, Crow’s feet, Nasolacrimal groove, lips, Perioral (bar code lines) and Neck

This product meets EU safety, health and environmental requirements

All popular payment methods

Out of stock

Novacutan FBio DVS Light is developed to achieve a subtle, natural-looking improvement of the skin. These fillers are ideal for use in areas where the skin is thin and delicate, such as around the eyes or on the lips. They can be used to smooth fine lines and wrinkles, fill hollow areas, and add volume to the skin. One of the greatest advantages of this lightweight filler is its subtle effect: the result is very natural, making it hardly noticeable that a filler has been used. In addition, lightweight fillers are easy to inject, causing minimal discomfort for the client.

Composition

Hyaluronic acid (HA) concentration: 20 mg/ml
Cross-linker: Divinyl sulfone
Type of hyaluronic acid: High molecular weight, cross-linked HA

Uniqueness

The three-dimensional structure of this gel is developed using the innovative 3 Design Visual System technology (3 DVS technology).

Areas of application

Frown lines
Crow’s feet
Tear troughs
Lips
Perioral wrinkles (barcode lines)
Neck

How FBio DVS Light works

Softens fine lines and superficial wrinkles.
Stimulates collagen production, improving skin elasticity and firmness.
Provides deep hydration for enhanced skin structure.

Who is FBio DVS Light suitable for?

People looking to correct small wrinkles, such as frown lines, crow’s feet, and perioral lines.
Clients seeking subtle rejuvenation and intensive hydration for a fresh, youthful appearance.

Benefits of FBio DVS Light

Improves skin texture with a subtle, natural lift.
Delivers deep tissue hydration and long-lasting results.
Ideal for sensitive areas such as the forehead, eyes, and lips.

Safety

This filler undergoes a triple HA purification process, making it non-immunogenic, non-allergenic, and fully biodegradable. Safety and efficacy are clinically and laboratory proven. No recovery time is required. The biological breakdown into smaller microspheres minimizes the risk of embolism.